Results 11 to 20 of about 10,191,051 (291)
Trends and future projections of Hodgkin and Non-Hodgkin lymphoma burden in Chinese children and adolescents (1990–2043): insights from the GBD 2023 database [PDF]
Annals of HematologyTo analyze the spatiotemporal trends and predict the future burden of Hodgkin lymphoma and non-Hodgkin lymphoma among children and adolescents in China from 1990 to 2023, using data from the Global Burden of Disease 2023 database.
Yanchao Li +11 more
doaj +2 more sources
The Non-Hodgkin's Lymphomas [PDF]
Ca-A Cancer Journal for Clinicians, 1985 J E Ultmann
exaly +3 more sources
Composite follicular lymphoma and classic Hodgkin lymphoma [PDF]
Journal of Pathology and Translational Medicine, 2022 Composite lymphoma is very rare and a combination of Hodgkin lymphoma and non-Hodgkin lymphoma and even histiocytic tumors can occur. Because of the unfamiliarity, not only can this cause diagnostic problems, but can also affect treatment plan. We report
Han-Na Kim +5 more
doaj +1 more source
Composite Lymphoma: Hodgkin and Non-Hodgkin Lymphoma A Case Report [PDF]
Jurnal Penyakit Dalam Indonesia, 2018 Composite lymphoma (CL) is a rare disease. Composite lymphoma is two or more different type of lymphoma that sequentially or simultaneously occur in one anatomical site.
Noorwati Soetandyo +3 more
doaj +2 more sources
The function and origin of the CD4+ T cell in the classical Hodgkin lymphoma microenvironment [PDF]
, 2012 PhDClassical Hodgkin lymphoma (CHL) is a germinal centre B cell malignancy where the bulk of the tumour comprises a non-clonal immune infiltrate enriched for CD4+ T cells.
Greaves, Paul
core +4 more sources
Head and Neck Lymphoma in an Iranian Population [PDF]
Iranian Journal of Otorhinolaryngology, 2017 Introduction: This study is aimed to assess the prevalence and characteristics of head and neck lymphoma in a defined group of an Iranian population. Materials and Methods: In this retrospective study, 126,450 biopsy reports from two referral Pathology
Nafiseh Shamloo +5 more
doaj +1 more source
Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma. [PDF]
Clin Pharmacol TherExternal control (EC) arms using routine data can be used as comparators in clinical trials under certain conditions. The objective of this study was to assess the ability of an EC arm to replicate outcomes of a randomized controlled trial (RCT) arm receiving the same treatment strategy in advanced stage classical Hodgkin lymphoma and serve as ...
Febvey-Combes O +8 more
europepmc +2 more sources
Molecular mechanisms of follicular lymphoma and its transformation [PDF]
, 2011 PhDFollicular lymphoma (FL) is the second most common form of non-Hodgkin lymphoma and at least a third of cases undergo aggressive transformation (t-FL), most frequently to diffuse large B-cell lymphoma.
Wrench, David John
core +4 more sources
The Egyptian Journal of Radiology and Nuclear Medicine, 2021 Background Malignant lymphoma accounts for nearly 20% of all mediastinal neoplasms in adults and 50% in children. Hodgkin’s disease is the most common primary mediastinal lymphoma.
Youssriah Yahia Sabri +3 more
doaj +1 more source
Journal of Contemporary Medicine, 2022 Aim: To evaluate the demographic and clinical characteristics, treatment approaches and outcomes of our pediatric patients with non-Hodgkin lymphoma diagnosed and treated in our center. Material and Methods: Between 2006 and 2002, the oncologic charts of
Kübra Ertan +3 more
doaj +1 more source